130 related articles for article (PubMed ID: 10349363)
1. Sensitivity studies of AutoPap System Location-Guided Screening of cervical-vaginal cytologic smears.
Huang TW; Lin TS; Lee JS
Acta Cytol; 1999; 43(3):363-8. PubMed ID: 10349363
[TBL] [Abstract][Full Text] [Related]
2. A feasibility study of the AutoPap system location-guided screening.
Lee JS; Kuan L; Oh S; Patten FW; Wilbur DC
Acta Cytol; 1998; 42(1):221-6. PubMed ID: 9479344
[TBL] [Abstract][Full Text] [Related]
3. The AutoPap system for primary screening in cervical cytology. Comparing the results of a prospective, intended-use study with routine manual practice.
Wilbur DC; Prey MU; Miller WM; Pawlick GF; Colgan TJ
Acta Cytol; 1998; 42(1):214-20. PubMed ID: 9479343
[TBL] [Abstract][Full Text] [Related]
4. Can technology expedite the cervical cancer screening process? A Hong Kong experience using the AutoPap primary screening system with location-guided screening capability.
Chang AR; Lin WF; Chang A; Chong KS
Am J Clin Pathol; 2002 Mar; 117(3):437-43. PubMed ID: 11888083
[TBL] [Abstract][Full Text] [Related]
5. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: II. Prospective and archival sensitivity studies.
Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
Cancer; 1997 Dec; 81(6):343-7. PubMed ID: 9438459
[TBL] [Abstract][Full Text] [Related]
6. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: I. A prospective intended use study.
Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
Cancer; 1997 Dec; 81(6):337-42. PubMed ID: 9438458
[TBL] [Abstract][Full Text] [Related]
7. Validation of AutoPap primary screening system sensitivity and high-risk performance.
Tench WD
Acta Cytol; 2002; 46(2):296-302. PubMed ID: 11917576
[TBL] [Abstract][Full Text] [Related]
8. Performance of the AutoPap Primary Screening System in the detection of high-risk cases in cervicovaginal smears.
Alasio LM; Alphandery C; Grassi P; Ruggeri M; De Palo G; Pilotti S
Acta Cytol; 2001; 45(5):704-8. PubMed ID: 11575647
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of AutoPap system location-guided screening in the evaluation of cervical cytology smears.
Stevens MW; Milne AJ; Parkinson IH; Nespolon WW; Fazzalari NL; Arora N; Dodd TJ
Diagn Cytopathol; 2004 Aug; 31(2):94-9. PubMed ID: 15282720
[TBL] [Abstract][Full Text] [Related]
10. Detection of high grade squamous intraepithelial lesions and tumors using the AutoPap System: results of a primary screening clinical trial.
Wilbur DC; Prey MU; Miller WM; Pawlick GF; Colgan TJ; Dax Taylor D
Cancer; 1999 Dec; 87(6):354-8. PubMed ID: 10603189
[TBL] [Abstract][Full Text] [Related]
11. A feasibility study of the use of the AutoPap screening system as a primary screening and location-guided rescreening device.
Confortini M; Bonardi L; Bulgaresi P; Cariaggi MP; Cecchini S; Ciatto S; Cipparrone I; Galanti L; Maddau C; Matucci M; Rubeca T; Troni GM; Turco P; Zappa M; Carozzi F
Cancer; 2003 Jun; 99(3):129-34. PubMed ID: 12811852
[TBL] [Abstract][Full Text] [Related]
12. Location-guided screening of liquid-based cervical cytology specimens: a potential improvement in accuracy and productivity is demonstrated in a preclinical feasibility trial.
Wilbur DC; Parker EM; Foti JA
Am J Clin Pathol; 2002 Sep; 118(3):399-407. PubMed ID: 12219782
[TBL] [Abstract][Full Text] [Related]
13. Does use of the AutoPap assisted primary screener improve cytologic diagnosis?
Bibbo M; Hawthorne C; Zimmerman B
Acta Cytol; 1999; 43(1):23-6. PubMed ID: 9987445
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of automated cervical cytology rescreening using the AutoPap 300 QC System.
Stevens MW; Milne AJ; James KA; Brancheau D; Ellison D; Kuan L
Diagn Cytopathol; 1997 Jun; 16(6):505-12. PubMed ID: 9181316
[TBL] [Abstract][Full Text] [Related]
15. AutoPap system performance in screening for low prevalence and small cell abnormalities.
Lee JS; Wilhelm P; Kuan L; Ellison DG; Lei X; Oh S; Patten SF
Acta Cytol; 1997; 41(1):56-64. PubMed ID: 9022727
[TBL] [Abstract][Full Text] [Related]
16. Adenocarcinoma in situ of the cervix.
Schoolland M; Segal A; Allpress S; Miranda A; Frost FA; Sterrett GF
Cancer; 2002 Dec; 96(6):330-7. PubMed ID: 12478680
[TBL] [Abstract][Full Text] [Related]
17. Performance of the AutoPap primary screening system at Jefferson University Hospital.
Bibbo M; Hawthorne C
Acta Cytol; 1999; 43(1):27-9. PubMed ID: 9987446
[TBL] [Abstract][Full Text] [Related]
18. Cytologic and histologic review of atypical glandular cells (AGC) detected during cervical cytology screening.
Jeng CJ; Liang HS; Wang TY; Shen J; Yang YC; Tzeng CR
Int J Gynecol Cancer; 2003; 13(4):518-21. PubMed ID: 12911731
[TBL] [Abstract][Full Text] [Related]
19. Comparative sensitivities of ThinPrep and Papanicolaou smear for adenocarcinoma in situ (AIS) and combined AIS/high-grade squamous intraepithelial lesion (HSIL): comparison with HSIL.
Roberts JM; Thurloe JK
Cancer; 2007 Dec; 111(6):482-6. PubMed ID: 17969065
[TBL] [Abstract][Full Text] [Related]
20. Whole-Slide Imaging of Pap Cellblock Preparations Is a Potentially Valid Screening Method.
Tawfik O; Davis M; Dillon S; Tawfik L; Diaz FJ; Amin K; Fan F
Acta Cytol; 2015; 59(2):187-200. PubMed ID: 25967603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]